Wednesday, March 16, 2016

5 Healthcare Stocks With Growing Dividends Yielding In Excess of 2%

As we age, our need for medical services, devices and medications seems to increase as each year passes. Sometimes the medical product or service that meets our needs will provide a better quality of life, and often they are also life sustaining. We rely on companies in the Healthcare Sector to supply the medical needs of our population.

The Healthcare Sector includes organizations specializing in hospital management, health maintenance organizations (HMOs), biotechnology and medical products. Stocks in these companies are often considered defensive due to a consistent demand for their goods and services. Thus, this sector is less sensitive to economic cycles.

One surety in life is that we will continue to age until we die. As we age, our heath eventually begins to decline. Unfortunately, the Healthcare Sector will never become obsolete. However, understanding this provides us with investment opportunities in quality dividend growth stocks.

This week, I screened my dividend growth stocks database for healthcare companies with a yield at or above 2% and have increased their dividends for at least 10 consecutive years. The results are presented below:

Medtronic Inc. (MDT) is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management and other medical markets. The company has paid a cash dividend to shareholders every year since 1977 and has increased its dividend payments for 38 consecutive years. Yield: 2.0%

Owens & Minor Inc. (OMI) is a leading domestic distributor of medical and surgical supplies to the acute care market, a health care supply chain management company, and a direct-to-consumer (DTC) supplier of testing and monitoring supplies for diabetes. The company has paid a cash dividend to shareholders every year since 1926 and has increased its dividend payments for 17 consecutive years. Yield: 2.5%

Abbott Laboratories (ABT) is a diversified health care products company that is now focused on nutritionals, diagnostics, generic drugs, and medical devices, following the spinoff of its R&D-based prescription pharmaceuticals business. The company has paid a cash dividend to shareholders every year since 1926 and has increased its dividend payments for 44 consecutive years. Yield: 2.6%

Johnson & Johnson (JNJ) is a leader in the pharmaceutical, medical device and consumer products industries. The company has paid a cash dividend to shareholders every year since 1944 and has increased its dividend payments for 53 consecutive years. Yield: 2.8%

Abbvie Inc. (ABBV) is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis. The company has paid a cash dividend to shareholders every year since 1926 and has increased its dividend payments for 43 consecutive years. Yield: 4.0%

As with past screens, the data presented above is in its raw form. Some of the the companies would be disqualified for poor dividend fundamentals. However some of the others may be worth additional due diligence.

My database, D4L-Data, is an Open Office spreadsheet containing more than 20 columns of information on the 250+ companies that I track. The data is sortable and has built-in buttons and macros to make it easy to use. Companies included in the list are those that have had a history of dividend growth. The D4L-Data spreadsheet is a part of D4L-Premium Services and is updated each Saturday for subscribers.

Full Disclosure: No Long JNJ, ABBV. See a list of all my Dividend Growth Portfolio Holdings here.

Related Articles
- 4 High-Yielding Utilities With A Growing Dividends
- 9 Dividend Stocks With A 10%+ Dividend Growth Rate
- 3 Styles Of Successful Dividend Investing
- Why Dividend Growth Stocks Are Evil
- Building Yield: 7 Consumer Goods Dividend Stocks

(Photo Credit)


Tags: MDT, OMI, ABT, JNJ, ABBV,